KKR & Co. Inc. (NYSE:KKR) Price Target Raised to $150.00

KKR & Co. Inc. (NYSE:KKR) had its target price boosted by Evercore ISI from $130.00 to $150.00 in a report published on Thursday,Benzinga reports. They currently have an outperform rating on the asset manager’s stock.

KKR has been the topic of a number of other research reports. Hsbc Global Res downgraded KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Keefe, Bruyette & Woods upped their price target on KKR & Co. Inc. from $129.00 to $131.00 and gave the stock an “outperform” rating in a research note on Friday, May 2nd. JMP Securities decreased their price target on KKR & Co. Inc. from $165.00 to $150.00 and set a “market outperform” rating for the company in a research note on Tuesday, April 8th. Barclays upped their price target on KKR & Co. Inc. from $129.00 to $141.00 and gave the stock an “overweight” rating in a research note on Friday, May 2nd. Finally, Piper Sandler began coverage on KKR & Co. Inc. in a research note on Monday, June 30th. They set an “overweight” rating and a $150.00 price target for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, KKR & Co. Inc. currently has a consensus rating of “Moderate Buy” and a consensus price target of $155.20.

KKR & Co. Inc. Stock Performance

Shares of NYSE KKR opened at $141.13 on Thursday. The business’s 50-day moving average price is $125.56 and its two-hundred day moving average price is $128.43. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.08 and a quick ratio of 0.08. KKR & Co. Inc. has a one year low of $86.15 and a one year high of $170.40. The company has a market capitalization of $125.70 billion, a P/E ratio of 59.55, a price-to-earnings-growth ratio of 1.58 and a beta of 1.88.

KKR & Co. Inc. (NYSE:KKR) last issued its earnings results on Thursday, May 1st. The asset manager reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.13 by $0.02. KKR & Co. Inc. had a return on equity of 6.43% and a net margin of 14.75%. The firm had revenue of $1.77 billion for the quarter, compared to the consensus estimate of $1.71 billion. During the same quarter in the previous year, the company posted $0.97 earnings per share. The business’s quarterly revenue was down 67.8% compared to the same quarter last year. Analysts anticipate that KKR & Co. Inc. will post 5.19 earnings per share for the current fiscal year.

KKR & Co. Inc. Increases Dividend

The firm also recently disclosed a dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were given a $0.185 dividend. This represents a dividend yield of 0.64%. This is a boost from KKR & Co. Inc.’s previous dividend of $0.17. The ex-dividend date of this dividend was Monday, May 12th. KKR & Co. Inc.’s dividend payout ratio is currently 31.22%.

Insider Buying and Selling

In other KKR & Co. Inc. news, Director Robert W. Scully acquired 13,250 shares of KKR & Co. Inc. stock in a transaction dated Tuesday, May 6th. The stock was bought at an average cost of $113.49 per share, with a total value of $1,503,742.50. Following the completion of the transaction, the director owned 13,250 shares of the company’s stock, valued at $1,503,742.50. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $34.20, for a total value of $205,200,000.00. Following the completion of the sale, the insider directly owned 13,260,971 shares of the company’s stock, valued at $453,525,208.20. This represents a 31.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,471,488 shares of company stock valued at $501,529,092 in the last ninety days. Company insiders own 39.34% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Bruce G. Allen Investments LLC raised its stake in shares of KKR & Co. Inc. by 13.9% in the second quarter. Bruce G. Allen Investments LLC now owns 589 shares of the asset manager’s stock valued at $78,000 after purchasing an additional 72 shares in the last quarter. PFG Advisors raised its stake in KKR & Co. Inc. by 4.5% during the first quarter. PFG Advisors now owns 2,071 shares of the asset manager’s stock worth $239,000 after acquiring an additional 90 shares in the last quarter. Chemistry Wealth Management LLC raised its stake in KKR & Co. Inc. by 0.7% during the second quarter. Chemistry Wealth Management LLC now owns 12,239 shares of the asset manager’s stock worth $1,628,000 after acquiring an additional 90 shares in the last quarter. First Bank & Trust raised its stake in KKR & Co. Inc. by 1.3% during the first quarter. First Bank & Trust now owns 7,422 shares of the asset manager’s stock worth $858,000 after acquiring an additional 98 shares in the last quarter. Finally, LRI Investments LLC raised its stake in KKR & Co. Inc. by 9.9% during the fourth quarter. LRI Investments LLC now owns 1,110 shares of the asset manager’s stock worth $164,000 after acquiring an additional 100 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.